NEVVI Medicare utilization intelligence

← back

GUPTA, SAMEERMD, MPH NPI 1013171420 Clinician

Hematology-Oncology · BRYN MAWR, PA

Specialty Hematology-Oncology — from billed Medicare claims
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 58 codes billed · 399,829 disclosed volume (CY2024 — most recent year in data)
Current groups
Hospital affiliations
  • BRYN MAWR HOSPITAL · Hospital · CCN 390139
  • HOSPITAL OF UNIV OF PENNSYLVANIA · Hospital · CCN 390111
  • MAIN LINE HOSPITAL LANKENAU · Hospital · CCN 390195
  • PAOLI HOSPITAL · Hospital · CCN 390153
  • RIDDLE MEMORIAL HOSPITAL · Hospital · CCN 390222
  • Home health agency — CCN 397012
  • Inpatient rehabilitation facility — CCN 393025
  • Long-term care hospital — CCN 392050
registry affiliations from the CMS Doctors & Clinicians facility file — an administrative affiliation, not a statement about where care is delivered

Group affiliation since 2019

Notify me at launch →

Membership spans across every group on this clinician's 2019+ registry record, departed groups included. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2017-04
Data year CY2024 CY2023 CY2022 locked column CY2021 locked column CY2020 locked column

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The full billed-volume analytics for this provider — its position among specialty peers, practice focus, and the payments behind it — computed from the same disclosed Medicare Part B data.

This provider's disclosed submitted charges across all codes were premium in CY2024. Included with Platform.

  • Charge, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Volume locked column Beneficiary-episodes locked column Avg charge locked column Avg Medicare payment locked column
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) premiumpremium premiumpremium
Q5110 Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram premiumpremium premiumpremium
J9299 Injection, nivolumab, 1 mg premiumpremium premiumpremium
J1453 Injection, fosaprepitant, 1 mg premiumpremium premiumpremium
J9271 Injection, pembrolizumab, 1 mg premiumpremium premiumpremium
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj premiumpremium premiumpremium
J0897 Injection, denosumab, 1 mg premiumpremium premiumpremium
J9267 Injection, paclitaxel, 1 mg premiumpremium premiumpremium
J1456 Injection, fosaprepitant (teva), not therapeutically equivalent to j1453, 1 mg premiumpremium premiumpremium
J1437 Injection, ferric derisomaltose, 10 mg premiumpremium premiumpremium
J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg premiumpremium premiumpremium
J1626 Injection, granisetron hydrochloride, 100 mcg premiumpremium premiumpremium
J2919 Injection, methylprednisolone sodium succinate, 5 mg premiumpremium premiumpremium
96375 Injection of additional new drug or substance into vein premiumpremium premiumpremium
J9041 Injection, bortezomib, 0.1 mg premiumpremium premiumpremium
Q5108 Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg premiumpremium premiumpremium
J9395 Injection, fulvestrant, 25 mg premiumpremium premiumpremium
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more premiumpremium premiumpremium
J2469 Injection, palonosetron hcl, 25 mcg premiumpremium premiumpremium
J2405 Injection, ondansetron hydrochloride, per 1 mg premiumpremium premiumpremium
J1100 Injection, dexamethasone sodium phosphate, 1 mg premiumpremium premiumpremium
J3490 Unclassified drugs premiumpremium premiumpremium
36415 Insertion of needle into vein for collection of blood sample premiumpremium premiumpremium
96372 Injection of drug or substance under skin or into muscle premiumpremium premiumpremium
96413 Administration of chemotherapy into vein, 1 hour or less premiumpremium premiumpremium

Showing the top 25 of 58 procedures this clinician billed. The full list is part of the premium platform. Notify me at launch →

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.